0.7846
前日終値:
$0.7693
開ける:
$0.777
24時間の取引高:
137.17K
Relative Volume:
0.60
時価総額:
$39.23M
収益:
$2.82M
当期純損益:
$-13.47M
株価収益率:
-1.1538
EPS:
-0.68
ネットキャッシュフロー:
$-13.61M
1週間 パフォーマンス:
-4.29%
1か月 パフォーマンス:
-23.83%
6か月 パフォーマンス:
-31.77%
1年 パフォーマンス:
-0.68%
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
名前
Neuroone Medical Technologies Corp
セクター
電話
(952) 426-1383
住所
7599 ANAGRAM DR, EDEN PRAIRIE
NMTC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
0.99 | 0 | 0 | 0 | 0 | 0.00 | |
![]()
MOBBW
Mobilicom Limited Warrants
|
0.92 | 1.26B | 0 | 0 | 0 | 0.00 |
![]()
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
![]()
SHMD
Schmid Group N V
|
2.53 | 110.24M | 0 | 0 | 0 | 0.00 |
![]()
PSNYW
Polestar Automotive Holding Uk
|
0.1668 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
![]()
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-05 | 開始されました | Ladenburg Thalmann | Buy |
2022-03-29 | ダウングレード | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp (NMTC) 最新ニュース
Is NeuroOne Medical Technologies Corporation stock ready for a breakout2025 Price Targets & Long-Term Investment Growth Plans - Newser
Can you recover from losses in NeuroOne Medical Technologies CorporationJuly 2025 Drop Watch & Real-Time Volume Analysis - Newser
Real time alert setup for NeuroOne Medical Technologies Corporation performance2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser
What recovery options are there for NeuroOne Medical Technologies CorporationPortfolio Performance Report & High Return Trade Guides - Newser
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment - Yahoo Finance
Does NeuroOne Medical Technologies Corporation qualify in momentum factor screeningInsider Selling & Fast Gain Swing Alerts - Newser
NeuroOne’s nerve ablation system secures FDA clearance - Yahoo Finance
Published on: 2025-08-19 04:28:57 - Newser
Market reaction to NeuroOne Medical Technologies Corporation’s recent news2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
Is NeuroOne Medical Technologies Corporation reversing from oversold territoryMarket Volume Summary & Free Verified High Yield Trade Plans - Newser
What makes NeuroOne Medical Technologies Corporation stock price move sharplyProduct Launch & Real-Time Stock Movement Alerts - Newser
NeuroOne Medical Technologies receives FDA clearance for OneRF system - Investing.com
First-of-its-Kind Pain Treatment: NeuroOne's OneRF System Gets FDA Green Light for 150K Facial Pain Patients - Stock Titan
Analyzing recovery setups for NeuroOne Medical Technologies Corporation investorsJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Is NeuroOne Medical Technologies Corporation stock entering bullish territoryWeekly Earnings Recap & Verified Momentum Stock Alerts - Newser
What the charts say about NeuroOne Medical Technologies Corporation todayWeekly Trade Review & AI Enhanced Market Trend Forecasts - Newser
What technical models suggest about NeuroOne Medical Technologies Corporation’s comebackStop Loss & Weekly High Potential Stock Alerts - Newser
NeuroOne Medical Technologies Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Reversal indicators forming on NeuroOne Medical Technologies Corporation stockJuly 2025 Retail & Risk Adjusted Buy/Sell Alerts - Newser
Using fundamentals and technicals on NeuroOne Medical Technologies CorporationTrend Reversal & Safe Capital Growth Trade Ideas - Newser
NeuroOne Medical Technologies' $8.0M Share Sale: A Strategic Move to Fuel Innovation and Secure Long-Term Growth - AInvest
NeuroOne Medical Technologies files updated $6.75 million at-the-market offering - Investing.com Australia
NeuroOne Medical Technologies files updated $6.75 million at-the-market offering By Investing.com - Investing.com South Africa
Does NeuroOne Medical Technologies Corporation show high probability of reboundTrade Exit Report & Comprehensive Market Scan Insights - Newser
NeuroOne Q3 Revenue Jumps 105 Percent - AOL.com
NeuroOne Medical Technologies Corp Exceeds Q3 FY2025 Earnings Estimates with 105% Increase in Product Revenue - AInvest
NeuroOne (NMTC) Q3 2025 Earnings Call Transcript - AOL.com
NeuroOne Q3 Revenue Jumps 105 Percent - The Motley Fool
NeuroOne Medical Technologies Corporation shares fall 2.33% intraday after Q3 2025 financial results conference call. - AInvest
NeuroOne Medical (NMTC): A High-Conviction Long-Term Play in Med-Tech Innovation - AInvest
NeuroOne Medical Technologies Corporation Q3 2025 Earnings Call Transcript: Financial Progress and Product Advancements - AInvest
NeuroOne's Q3 2025 Earnings Call: Key Contradictions in Product Development, Revenue, and FDA Pathways - AInvest
Earnings call transcript: NeuroOne Medical Q3 2025 beats revenue expectations - Investing.com Canada
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports Strong Q3 FY2025 Financial Results - TradingView
NeuroOne reports Q3 FY25 rev. $1.7 mln, up 105% YoY, completes $8.2 mln capital raise. - AInvest
NeuroOne Medical Technologies Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
NeuroOne Medical NMTC Q3 2025 Earnings Preview Upside Potential Driven by FDA Approvals and Strategic Partnerships - AInvest
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionFree Short Term Buy Zone Stock Alerts - Newser
Exit strategy if you’re trapped in NeuroOne Medical Technologies Corporation - Newser
Can NeuroOne Medical Technologies Corporation hit a new high this monthReal Time Screener for Growth Trades - Newser
Published on: 2025-08-10 05:12:13 - Newser
Published on: 2025-08-08 23:32:40 - Newser
NeuroOne Medical Technologies Corporation stock retracement – recovery analysisAI Screener for Daily Stock Forecast - Newser
Why NeuroOne Medical Technologies Corporation is moving todayPrice Action Trading with Volume Confirmation - Newser
Neuroone Medical Technologies Corp (NMTC) 財務データ
収益
当期純利益
現金流量
EPS
Neuroone Medical Technologies Corp (NMTC) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Christianson Mark | Business Development Director |
Jun 04 '25 |
Sale |
0.58 |
10,000 |
5,804 |
261,491 |
Christianson Mark | Business Development Director |
May 22 '25 |
Sale |
0.62 |
8,967 |
5,586 |
271,491 |
Christianson Mark | Business Development Director |
May 21 '25 |
Sale |
0.65 |
14 |
9 |
280,458 |
Christianson Mark | Business Development Director |
May 19 '25 |
Sale |
0.67 |
8,006 |
5,330 |
283,485 |
Christianson Mark | Business Development Director |
May 20 '25 |
Sale |
0.66 |
3,013 |
1,976 |
280,472 |
McClurg Ronald W. | Chief Financial Officer |
Apr 04 '25 |
Buy |
0.50 |
200,000 |
100,000 |
444,117 |
Rosa David A | CEO and President |
Apr 04 '25 |
Buy |
0.50 |
100,000 |
50,000 |
1,161,289 |
大文字化:
|
ボリューム (24 時間):